- Treatment of prostate cancer in the Czech Republic in 2016: outcomes of workshops on metastatic castration-resistant prostate cancer (mCRPC)2017 | Second Faculty of Medicine
- Komentář ke studii (Léčba pacientů s mCRPC - výsledky z evropské databáze FLAC)2018 | First Faculty of Medicine
- Péče o pacienty s mCRPC v datech2016 | First Faculty of Medicine
- Radium-223 jako účinná součást léčebného schématu u mCRPC2019 | First Faculty of Medicine
- ARPI (ANDROGEN RECEPTOR PATHWAY INHIBITORS) IN THE TREATMENT OF METASTATIC PROSTATE CARCINOMA, RESULTS FROM ONE SITEPublication without faculty affiliation
- ARTA treatment of metastatic castration-resistant prostate cancer - case report2021 | First Faculty of Medicine
- An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA)2019 | Faculty of Medicine in Pilsen
- Cabazitaxel for the treatment of metastatic castration-resistant prostate cancer2016 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Options of Chemotherapy in the Treatment of Prostate Cancer2017 | First Faculty of Medicine
- Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-resistant Prostate Cancer after Chemotherapy2016 | First Faculty of Medicine
- Enzulutamide in treatment in patients with metastatic castration-resistant prostate cancer after previous chemotherapy2017 | First Faculty of Medicine
- AR-V7 androgen receptor variant as a predictor of response to androgen-receptor targeting agents used to treat castration-refractory metastatic prostate cancer2018 | First Faculty of Medicine
- Enzalutamide and abiraterone in the treatment of patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy2023 | First Faculty of Medicine
- What the results of current studies with enzalutamide say - a commentary on the studies2021 | Publication without faculty affiliation
- Vhodný pacient pro léčbu abirateron acetátem2017 | First Faculty of Medicine
- Zkušenosti s léčbou abirateronem u pacienta s karcinomem prostaty2020 | First Faculty of Medicine
- Efektivita a bezpečnost léčby abirateron acetátem u pacientů s metastatickým kastračně rezistentním karcinomem prostaty po chemoterapii - výsledky studie 212082PCR3001 v České republicePublication without faculty affiliation
- Treatment of lung metastases in prostate cancer - case reports2021 | Third Faculty of Medicine
- Radionuclide therapy bone involvement in generalized prostate carcinoma2015 | First Faculty of Medicine
- Enzalutamide before chemotherapy in the treatment of metastatic castration-resistant prostate2019 | First Faculty of Medicine
- Komentář ke studii2015 | First Faculty of Medicine
- Chemoterapie pro hormonálně senzitivní karcinom prostaty2017 | First Faculty of Medicine
- Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience2023 | Faculty of Medicine in Pilsen
- Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate2024 | Faculty of Medicine in Pilsen
- Účinnost enzalutamidu v léčbě metastatického kastračně rezistentního karcinomu prostaty2020 | First Faculty of Medicine
- Expanded access protocol with abiraterone acetate for metastatic castration-resistant prostate cancer post-chemoterapy - results in Czech RepublicPublication without faculty affiliation
- The expression of PD-L1 in patients with castrate prostate cancer treated with enzalutamide2018 | First Faculty of Medicine
- Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer The VIABLE Phase 3 Randomized Clinical Trial2022 | Faculty of Medicine in Hradec Králové
- Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate CancerPublication without faculty affiliation
- Radium-223 v klinické praxi2020 | First Faculty of Medicine